Differentiation between cancerous and normal hyperplastic lobules in breast lesions

Breast Cancer Research and Treatment

Volumn 83, Issue 1, 2004, Pages 1-10

  Slater, Michael ^a   Danieletto, Suzanne ^b   Pooley, Margaret ^c   Teh, Liew Cheng ^a   Gidley Baird, Angus ^a   Barden, Julian A ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b SYDNEY ADVENTIST HOSPITAL   (Australia)

^c Specialist Medical Centre   (Australia)

Author keywords

Apoptosis; Breast cancer; Early diagnosis; P2X7 receptors

Indexed keywords

PURINE P2X7 RECEPTOR; RECEPTOR ANTIBODY;

APOPTOSIS; ARTICLE; BREAST BIOPSY; BREAST CARCINOMA; BREAST HYPERPLASIA; CANCER CELL; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER INVASION; CARCINOMA IN SITU; CLINICAL EXAMINATION; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; EARLY DIAGNOSIS; EPITHELIUM CELL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LABORATORY TEST; PRIORITY JOURNAL;

BREAST; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CARCINOMA, LOBULAR; FEMALE; FIBROCYSTIC BREAST DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; PRECANCEROUS CONDITIONS; PREDICTIVE VALUE OF TESTS; RECEPTORS, PURINERGIC P2;

EID: 0942301260     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:BREA.0000010670.85915.0f     Document Type: Article

References (25)

1. Jarasch ED, Nagle RB, Kaufmann M, Maurer C, Bocker WJ: Differential diagnosis of benign epithelial proliferations and carcinomas of the breast using antibodies to cytokeratins. Hum Pathol 19: 276-289, 1988
2. Bodian CA, Perzin KH, Lattes R, Hoffmann P: Reproducibility and validity of pathologic classifications of benign breast disease and implications for clinical applications. Cancer 71: 3908-3913, 1993
3. Batori M, Gallinaro LS, D'Urso A, Ruggeri M, Lorusso R, Forte A, Fierro N: Papillomatosis and breast cancer: a case report and a review of the literature. Eur Rev Med Pharm Sci 4: 99-103, 2000
4. Jacobs TW, Connolly JL, Schnitt SJ: Nonmalignant lesions in breast core needle biopsies: to excise or not to excise? Am J Surg Pathol 26: 1095-1110, 2002
5. Fearon ER: Human cancer syndromes: clues to the origin and nature of cancer. Science 278: 1043-1050, 1997
6. Cohen SM, Ellwein LB: Genetic errors, cell proliferation, and carcinogenesis. Cancer Res 51: 6493-6505, 1991
7. Connolly J: Principles of cancer pathology. In: Holland J (ed) Cancer Medicine. Williams and Williams. Baltimore, 1997, p 533
8. Allred DC, Mohsin SK, Fuqua SA: Histological and biological evolution of human premalignant breast disease. Endocr-Relat-Cancer 8: 47-61, 2001
9. Russo J, Russo IH: The pathway of neoplastic transformation of human breast epithelial cells. Radiat Res 155: 151-154, 2001
10. Gong G, DeVries S, Chew KL, Cha I, Ljung BM, Waldman FM: Genetic changes in paired atypical and usual ductal hyperplasia of the breast by comparative genomic hybridization. Clin Can Res 7: 2410-2414, 2001
11. Mommers EC, van Diest PJ, Leonhart AM, Meijer CJ, Baak JP: Expression of proliferation and apoptosis-related proteins in usual ductal hyperplasia of the breast. Hum Pathol 29: 1539-1545, 1998
12. Mommers EC, Leonhart AM, Falix F, Michalides R, Meijer CJ, Baak JP, Diest PJ: Similarity in expression of cell cycle proteins between in situ and invasive ductal breast lesions of same differentiation grade. J Pathol 194: 327-333, 2001
13. Alo PL, Visca P, Botti C, Galati GM, Sebastiani V, Andreano T, Di Tondo U, Pizer ES: Immunohistochemical expression of human erythrocyte glucose transporter and fatty acid synthase in infiltrating breast carcinomas and adjacent typical/atypical hyperplastic or normal breast tissue. Am J Clin Pathol 116: 129-134, 2001
14. Umbricht CB, Evron E, Gabrielson E, Ferguson A, Marks J, Sukumar S: Hypermethylation of 14-3-3 sigma (stratifin) is an early event in breast cancer. Oncogene 20: 3348-3353, 2001
15. Diallo R, Schaefer KL, Poremba C, Shivazi N, Willmann V, Buerger H, Dockhorn-Dworniczak B, Boecker W: Monoclonality in normal epithelium and in hyperplastic and neoplastic lesions of the breast. J Pathol 193: 27-32, 2001
16. Washington C, Dalbegue F, Abreo F, Taubenberger JK, Lichy JH: Loss of heterozygosity in fibrocystic change of the breast: genetic relationship between benign proliferative lesions and associated carcinomas. Am J Pathol 157: 323-329, 2000
17. Slater M, Lauer C, Gidley-Baird A, Barden JA: Markers for the development of early prostate cancer. J Pathol 199: 368-377, 2002
18. Slater M, Scolyer RA, Gidley-Baird A, Barden JA: (2003) Increased expression of apoptotic markers in melanoma. Melanoma Res 13: 1-9, 2003
19. 7 receptors in HEK293 cells and B-lymphocytes. FEBS Lett 538: 159-162, 2003
20. 5 receptors in adults with overactive detrusor contractility and urge incontinence. J Neurosci 21: U17-U22, 2001
21. Slater M, Delprado WJ, Murphy CR, Barden JA: Detection of preneoplasia in histologically normal prostate biopsies. Prost Cancer Prost Dis 4: 92-96, 2002
22. Parton M, Dowsett M. Smith I: Studies of apoptosis in breast cancer. Br Med J 322: 1528-1532, 2001
23. Page DL: Cancer risk assessment in benign breast biopsies. Hum Pathol 17: 871-874, 1986
24. Lennington WJ, Jensen RA, Dalton LW, Page DL: Ductal carcinoma in situ of the breast. Heterogeneity of individual lesions. Cancer 73: 118-124, 1994
25. Rosen PP, Oberman HA: Tumors of the Mammary Gland. Armed Forces Institute of Pathology, Washington DC, 1993